Cannabis Beverage Brand FIND WUNDER Joins Petalfast’s California Portfolio
IRVINE, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Petalfast, a route-through-market platform for the cannabis industry, announced its partnership with...
Month: March 2023
Dyadic to Report 2022 Year End Financial Results on Wednesday, March 29, 2023
JUPITER, Fla., March 15, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI),...
IR-Med to present at National Pressure Injury Advisory Panel 2023
The company’s PressureSafe device is being designed to reduce healthcare disparity in pressure injury detection and treatment Rosh Pina, Israel,...
MediGO Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023
The Baltimore-based digital healthcare supply chain technology company joins the ranks of OpenAI, Disney, Tiffany & Co., and moreBALTIMORE, March...
Progyny Enhances Male Fertility Offering with the Expansion of its Reproductive Urologist Network
NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility...
AXIM® Biotechnologies Files Provisional Patent on Novel Methodology for Use in Optical Diagnostic Assay Manufacturing
Leading Diagnostic Healthcare Company Announces Provisional Patent Filing on Proprietary Use of Materials for Ophthalmological Test Strip Manufacturing SAN DIEGO,...
IBA is looking for 100 new collaborators in Belgium by June 2023
Louvain-la-Neuve, Belgium, 14 March 2023 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology wants...
Vistant Named to Inc. Mid-Atlantic List
With Revenue Growth of 200 Percent, Recognition Highlights Company’s Ongoing SuccessTOWSON, Md., March 14, 2023 (GLOBE NEWSWIRE) -- Vistant, a...
Clearmind Medicine Appoints Professor Henry R. Kranzler, M.D., to Scientific Advisory Board
Professor Kranzler is the Benjamin Rush Professor of Psychiatry and Director of the Center for Studies of Addiction at the...
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
New Business Strategy Focused on Precision OncologyLONDON and HONG KONG, March 14, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:...
Roche Annual General Meeting 2023
All proposals of the Board of Directors approvedSeverin Schwan elected as new Chairman of the Board of Directors; all other...
357 Hemp Logistics’ President to Reveal Strategies for “Solving Logistics and Supply Chain Issues” at NoCo Hemp Expo, March 30th
The 357 Company Logistics issues can make or break a company. You can’t afford to miss the presentation on “Solving...
Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
SOUTH SAN FRANCISCO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools...
Predictive Oncology Engages LifeSci Advisors as Strategic Investor Relations Partner
Comprehensive, multi-faceted IR program to focus on raising awareness of Predictive Oncology and its portfolio of unique, proprietary assets capable...
Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference
Presentation with live webcast today, March 14th at 10:40 AM ETDURHAM, N.C., March 14, 2023 (GLOBE NEWSWIRE) -- Novan, Inc....
Ultragenyx Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President
Dr. Camille Bedrosian to continue employment as strategic development advisor with the company Eric Crombez, M.D. Eric Crombez, M.D.NOVATO, Calif.,...
Adamis Pharmaceuticals Announces $3.0 Million Registered Direct Offering
SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on...
electroCore Affirms No Direct Exposure to Silicon Valley Bank, Silvergate Bank, or Signature Bank
ROCKAWAY, N.J., March 14, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced...
Custom Research Presented at AMIA Informatics Summit Reveals Promising Findings for Healthcare Innovation
SAN FRANCISCO, March 14, 2023 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and...
LumiraDx to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Quarterly Conference Call on March 21
LONDON, March 14, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, announced it...